128 related articles for article (PubMed ID: 38158373)
1. "Light-On" Fluorescent Nanoprobes for Monitoring Dynamic Distribution of Cellular Nucleolin During Pyroptosis.
Kong J; Ju X; Qi G; Wang J; Diao X; Wang B; Zhang C; Li J; Jin Y
Anal Chem; 2024 Jan; 96(2):926-933. PubMed ID: 38158373
[TBL] [Abstract][Full Text] [Related]
2. Aptamer AS1411 utilized for super-resolution imaging of nucleolin.
Jing Y; Cai M; Zhou L; Jiang J; Gao J; Wang H
Talanta; 2020 Sep; 217():121037. PubMed ID: 32498876
[TBL] [Abstract][Full Text] [Related]
3. Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells.
Soundararajan S; Wang L; Sridharan V; Chen W; Courtenay-Luck N; Jones D; Spicer EK; Fernandes DJ
Mol Pharmacol; 2009 Nov; 76(5):984-91. PubMed ID: 19657047
[TBL] [Abstract][Full Text] [Related]
4. The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells.
Soundararajan S; Chen W; Spicer EK; Courtenay-Luck N; Fernandes DJ
Cancer Res; 2008 Apr; 68(7):2358-65. PubMed ID: 18381443
[TBL] [Abstract][Full Text] [Related]
5. Signalling probe displacement electrochemical aptasensor for malignant cell surface nucleolin as a breast cancer biomarker based on gold nanoparticle decorated hydroxyapatite nanorods and silver nanoparticle labels.
Farzin L; Shamsipur M; Samandari L; Sheibani S
Mikrochim Acta; 2018 Feb; 185(2):154. PubMed ID: 29594749
[TBL] [Abstract][Full Text] [Related]
6. Nanopipette-Based SERS Aptasensor for Subcellular Localization of Cancer Biomarker in Single Cells.
Hanif S; Liu HL; Ahmed SA; Yang JM; Zhou Y; Pang J; Ji LN; Xia XH; Wang K
Anal Chem; 2017 Sep; 89(18):9911-9917. PubMed ID: 28825473
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic applications of AS1411 aptamer, an update review.
Yazdian-Robati R; Bayat P; Oroojalian F; Zargari M; Ramezani M; Taghdisi SM; Abnous K
Int J Biol Macromol; 2020 Jul; 155():1420-1431. PubMed ID: 31734366
[TBL] [Abstract][Full Text] [Related]
8. AS1411 Nucleolin-Specific Binding Aptamers Reduce Pathological Angiogenesis through Inhibition of Nucleolin Phosphorylation.
Iturriaga-Goyon E; Vivanco-Rojas O; Magaña-Guerrero FS; Buentello-Volante B; Castro-Salas I; Aguayo-Flores JE; Gracia-Mora I; Rivera-Huerta M; Sánchez-Bartés F; Garfias Y
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884955
[TBL] [Abstract][Full Text] [Related]
9. AS1411-conjugated gold nanoparticles affect cell proliferation through a mechanism that seems independent of nucleolin.
Kabirian-Dehkordi S; Chalabi-Dchar M; Mertani HC; Le Guellec D; Verrier B; Diaz JJ; Mehrgardi MA; Bouvet P
Nanomedicine; 2019 Oct; 21():102060. PubMed ID: 31336175
[TBL] [Abstract][Full Text] [Related]
10. Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells.
Noaparast Z; Hosseinimehr SJ; Piramoon M; Abedi SM
J Drug Target; 2015; 23(6):497-505. PubMed ID: 25673264
[TBL] [Abstract][Full Text] [Related]
11. Direct investigations of interactions between nucleolins and aptamers on pancreatic cancer and normal cells by atomic force microscopy.
Li X; Chen L; Kong S; Zhong H; Jiang F; Zhao W
Ultramicroscopy; 2024 Sep; 263():113986. PubMed ID: 38762964
[TBL] [Abstract][Full Text] [Related]
12. Aptamer-based approaches to detect nucleolin in prostate cancer.
Miranda A; Santos T; Carvalho J; Alexandre D; Jardim A; Caneira CF; Vaz V; Pereira B; Godinho R; Brito D; Chu V; Conde JP; Cruz C
Talanta; 2021 May; 226():122037. PubMed ID: 33676639
[TBL] [Abstract][Full Text] [Related]
13. Direct observation of nanoparticle-cancer cell nucleus interactions.
Dam DH; Lee JH; Sisco PN; Co DT; Zhang M; Wasielewski MR; Odom TW
ACS Nano; 2012 Apr; 6(4):3318-26. PubMed ID: 22424173
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of doxorubicin and aptamer against Forkhead box M1 using chitosan-gold nanoparticles coated with nucleolin aptamer for synergistic treatment of cancer cells.
Khademi Z; Lavaee P; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
Carbohydr Polym; 2020 Nov; 248():116735. PubMed ID: 32919550
[TBL] [Abstract][Full Text] [Related]
15. Grafting aptamers onto gold nanostars increases in vitro efficacy in a wide range of cancer cell types.
Dam DH; Culver KS; Odom TW
Mol Pharm; 2014 Feb; 11(2):580-7. PubMed ID: 24422969
[TBL] [Abstract][Full Text] [Related]
16. AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin.
Cheng Y; Zhao G; Zhang S; Nigim F; Zhou G; Yu Z; Song Y; Chen Y; Li Y
PLoS One; 2016; 11(12):e0167094. PubMed ID: 27907160
[TBL] [Abstract][Full Text] [Related]
17. A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer.
Hwang DW; Ko HY; Lee JH; Kang H; Ryu SH; Song IC; Lee DS; Kim S
J Nucl Med; 2010 Jan; 51(1):98-105. PubMed ID: 20008986
[TBL] [Abstract][Full Text] [Related]
18. Regulation of nucleolin expression by miR-194, miR-206, and HuR.
Bose S; Tholanikunnel TE; Reuben A; Tholanikunnel BG; Spicer EK
Mol Cell Biochem; 2016 Jun; 417(1-2):141-53. PubMed ID: 27221739
[TBL] [Abstract][Full Text] [Related]
19. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
Mosafer J; Mokhtarzadeh A
Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
[TBL] [Abstract][Full Text] [Related]
20. A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism.
Reyes-Reyes EM; Teng Y; Bates PJ
Cancer Res; 2010 Nov; 70(21):8617-29. PubMed ID: 20861190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]